Q4 2024 Management View CEO Leonard Schleifer highlighted 10% revenue growth in Q4 2024, attributed to strong performance from Dupixent, Libtayo, and EYLEA HD. He emphasized the acceleration in EYLEA ...

Dr. Wimms brings extensive industry and clinical development experience in sleep medicine innovationNEW YORK and MELBOURNE, Australia, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Inc. (Nasdaq: IXHL), (Incannex ...

A practice in Texas, that employs concierge-level of care personalized for the patient and offers a holistic medicine approach. This practice emphasizes prevention, reduction of hospital admissions ...

Spirometry testing is used in the diagnosis of various lung conditions such as chronic obstructive pulmonary disease (COPD). Tuesday, January 28 saw the first patients attend the ...

Pharmaceuticals, a leading biotechnology company with a market capitalization of $71.75 billion, has been navigating a complex landscape of opportunities and challenges in recent months. According to ...

Dialysis Centers used data from the Centers for Disease Control and Prevention to examine the prevalence of chronic diseases in the U.S.

While this study focused on melanoma, air pollution has been linked to increased risk of other types of skin problems, including premature ageing, hyperpigmentation (a skin condition that causes ...

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...